We are live on ! Find out more
TLSI icon

TriSalus Life Sciences
TLSI

36 hedge funds and large institutions have $16.9M invested in TriSalus Life Sciences in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 11 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,000% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

37% more capital invested

Capital invested by funds: $12.4M → $16.9M (+$4.58M)

20% more funds holding

Funds holding: 30 → 36 (+6)

1.97% more ownership

Funds ownership: 8.09% → 10.06% (+2%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
36
Holders Change
+6
Holders Change %
+20%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
12
Increased
11
Reduced
1
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
+$4.33M
2
Millennium Management
Millennium Management
New York
+$281K
3
Goldman Sachs
Goldman Sachs
New York
+$180K
4
Citadel Advisors
Citadel Advisors
Florida
+$142K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$81.4K

Top Sellers

Rank Fund Capital Flow
1
DFO
Duquesne Family Office
New York
-$2.14M
2
AGC
Angelo Gordon & Co
New York
-$54.4K
3
EAM
Exos Asset Management
New York
-$18.1K
4
WAM
Wolverine Asset Management
Illinois
-$5.17K
5
TRCT
Tower Research Capital (TRC)
New York
-$2.78K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$37.6K +$36.1K +6,787 +30,850%
AAP
27
Arax Advisory Partners
Colorado
$22.1K +$21.3K +4,008 New
Morgan Stanley
28
Morgan Stanley
New York
$13K +$12.6K +2,361 New
Wells Fargo
29
Wells Fargo
California
$5.53K +$5.32K +1,000 +100,000%
Citigroup
30
Citigroup
New York
$5.29K +$5.1K +958 New
HRC
31
Hoertkorn Richard Charles
$3.69K – – –
JFG
32
JDM Financial Group
Texas
$2.93K – – –
CCM
33
Coldstream Capital Management
Washington
$828 +$799 +150 New
S
34
SignatureFD
Georgia
$552 – – –
Barclays
35
Barclays
United Kingdom
$177 +$170 +32 New
JP Morgan Chase
36
JP Morgan Chase
New York
$116 -$16 -3 -13%
DFO
37
Duquesne Family Office
New York
– -$2.14M -426,921 Closed
AGC
38
Angelo Gordon & Co
New York
– -$54.4K -10,854 Closed
EAM
39
Exos Asset Management
New York
– -$18.1K -3,604 Closed
WAM
40
Wolverine Asset Management
Illinois
– -$5.17K -1,032 Closed
TRCT
41
Tower Research Capital (TRC)
New York
– -$2.78K -555 Closed
Osaic Holdings
42
Osaic Holdings
Arizona
– -$395 -79 Closed
1
2

TLSI Hedge Fund Activity: Q1 2025 in Review

36 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q1 2025, worth a combined $16.9M — up 37% from $12.4M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new TLSI positions and 6 closed out — a net gain of 6 holders — while 11 added to existing stakes and 1 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $4.33M. The largest seller was Duquesne Family Office, exiting entirely with an estimated $2.14M sold.

  • 36 institutional investors held TriSalus Life Sciences (TLSI) as of Q1 2025, up from 30 in Q4 2024.
  • Funds reported $16.9M of TriSalus Life Sciences stock for Q1 2025, up 37% quarter-over-quarter.
  • 12 funds opened new TriSalus Life Sciences positions in Q1 2025 and 6 closed out, a net change of +6 holders.
  • The largest TriSalus Life Sciences buyer in Q1 2025 was Gilder Gagnon Howe & Co, an estimated $4.33M added.
  • The largest TriSalus Life Sciences seller in Q1 2025 was Duquesne Family Office, an estimated $2.14M sold.

Based on aggregated 13F filings for Q1 2025.